BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11692790)

  • 1. [Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998].
    Jenni D; Osterwalder R; Osswald S; Buser P; Pfisterer M
    Praxis (Bern 1994); 2001 Oct; 90(41):1759-65. PubMed ID: 11692790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D; Unal B; Critchley J; Capewell S
    QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times.
    Saab FA; Eagle KA; Kline-Rogers E; Fang J; Otten R; Mukherjee D;
    Am J Cardiol; 2004 Nov; 94(9):1166-8. PubMed ID: 15518612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure.
    Adabag AS; Nelson DB; Bloomfield HE
    Am Heart J; 2007 Dec; 154(6):1140-5. PubMed ID: 18035087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
    Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and survival outcomes in elderly patients with heart failure.
    Ray JG; Gong Y; Sykora K; Tu JV
    Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.
    Atar S; Cannon CP; Murphy SA; Rosanio S; Uretsky BF; Birnbaum Y
    Am Heart J; 2006 May; 151(5):976.e1-6. PubMed ID: 16644315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
    Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
    Hognestad A; Dickstein K; Myhre E; Snapinn S; Kjekshus J;
    Am J Cardiol; 2004 Mar; 93(5):603-6. PubMed ID: 14996587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Riba AL; Goswami RG; Peacock WF; Pollack CV; Collins SP; Gibler WB; Ohman EM; Peterson ED;
    Am J Cardiol; 2006 Jun; 97(12):1707-12. PubMed ID: 16765118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X; Gross CR; Schommer J; Cline R; St Peter WL
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
    Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
    Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.